Hypertriglyceridemia Induced Pancreatitis: Inpatient Management at a Single Pediatric Institution

Holly M Ippisch1, Ligia Alfaro-Cruz2, Lin Fei3

  • 1From the Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Pancreas
|March 14, 2020
PubMed

Insights

Hypertriglyceridemia-induced pancreatitis in children lacks guidelines. Management strategies like NPO, IV fluids, insulin, and plasmapheresis effectively lowered triglycerides, with NPO showing faster reduction.

Area of Science:

  • Pediatric Gastroenterology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Hypertriglyceridemia-induced acute pancreatitis (AP) is a significant pediatric concern.
  • Established management guidelines for this condition in children are lacking.
  • This study reviews management approaches at a single pediatric center.

Purpose of the Study:

  • To review and analyze management strategies for pediatric patients with hypertriglyceridemia-induced AP.
  • To identify factors influencing triglyceride reduction in this patient population.

Main Methods:

  • Retrospective study of pediatric inpatients (<21 years) with AP and triglycerides (TG) ≥1000 mg/dL.
  • Analysis of diet (NPO vs. early nutrition), intravenous fluid (IVF) rates, insulin, and plasmapheresis.
  • Linear mixed-effects model to assess TG reduction.

Main Results:

  • Seventeen admissions in 8 patients (average age 15) were analyzed.
  • Fifty percent experienced recurrent AP; 29% had complications, including one death.
  • NPO, higher IVF rates, plasmapheresis, and insulin were associated with significant TG reduction (P < 0.05).
  • NPO demonstrated faster TG reduction compared to early nutrition initiation.

Conclusions:

  • Hypertriglyceridemia is a key cause of pediatric pancreatitis.
  • A single institution's management algorithm for hypertriglyceridemia-induced AP is presented.
  • Further research is needed to develop evidence-based guidelines.
Abstract

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
639
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
233
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.0K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
616
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143